FDA recall D-0089-2024

Taro Pharmaceuticals Inc. · Class III · drug

Product

Hydrocortisone 1% and Acetic Acid 2% Otic Solution USP, 10ml dropper bottle, RX Only, Mfd. by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada LGT 1C, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532. NDC 51672-3007-1

Reason for recall

Failed Impurities/Degradation Specifications:Out-of-Specification result for Hydrocortisone related impurity and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.

Distribution

Nationwide in the USA

Key facts

Status
Terminated
Initiation date
2023-11-06
Report date
2023-11-15
Termination date
2024-08-27
Voluntary/Mandated
Voluntary: Firm initiated
Location
Brampton, Canada

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0089-2024